Dimitra Patton

One of eight selected to help build out the commercial sales team in preparation for launch of the first US commercially-licensed product for BeiGene. Responsible for the development and execution of strategic and tactical plans to exceed sales goals, drive engagement amongst team, and deliver an enterprise approach to supporting customer needs in collaboration with internal cross-functional partners.

• Hired, developed, and lead a high-performing hematology account management team to meet the needs of customers and drive business results
• Support and prioritize professional development of direct reports, which led to increased job responsibility/promotions for two sales professionals on team in 2021
• Selected as a member of Customer-facing Execution Launch Team (WM & MZL)
• Participant in LRRs and other launch activities for two new indications
• Helped lead Field Insights Task Force (WM, MZL, & CLL indications)
• Member of speakers bureau working group – liaison for field-based teams (’20-’22)
• DSM advisor for CLD Learning Champions Team (’20-’21), Engagement Team (’22-‘23), and Spark Marketing Team (’24)
• Lead cross-functional account planning for successful execution of launch strategy
• Selected by sales leadership to serve as a coach for the 2024 LEAD Program (Emerging Leaders Program)

Sales leader for a team of nine hematology oncology consultants. Led the development and execution of strategic and tactical plans to exceed sales goals across the entire Celgene portfolio, resource planning/allocation, and the overall performance of district sales team.

Experienced learning professional that was tasked with developing and implementing training processes for field sales in support of the Multiple Myeloma franchise strategy. Consistent performer and leader among peers and cross-functional colleagues.

• Was responsible for the development of classroom training programs, onboarding, and continuous training/development of hematology oncology consultants
• Collaborated with cross-functional partners to ensure alignment across functions, identify strategic business opportunities, maximize resources, and help implement brand strategies
• Developed innovative learning solutions to support the myeloma portfolio at national sales meetings through workshops and pull-through strategies to ensure learning retention
• Commercial Learning lead for the luspatercept (Reblozyl) launch in two disease states: Beta-Thalassemia and MDS
• Member of Joint Operating Team and strategic working groups for luspatercept launch
• Managed relationships with internal stakeholders as well as Acceleron co-promote partners for luspatercept launch
• Developed and executed hematology launch training blueprint (curriculum, workshops, and pull-through) that was used for multiple product launches in 2019
• Participant in Celgene’s Leadership Development program
• Onboarded and mentored new colleagues
• Managed and oversaw vendor partnerships

Managed the largest volume territory within the Chicago District with a focus on multiple myeloma. Responsible for engaging KOLs at two large academic universities and expanding knowledge and utilization of hematology portfolio among community Hematologists/Oncologists and the entire multidisciplinary team.

• Selected to lead workshops at national meetings.
• Finished year ranked in top 50% MM salesforce - 2016
• 2016 Marketing Advisory Committee member & Pomalyst Core Cross-Functional Team
• Led district workshop to review key messaging around triplet strategy
• Developed a District contest to motivate teammates and assist with pull-through of business objectives
• Finished first full year ranked #12 out of 139 representatives earning a Diamond Club Award
• Improved the management and dispensing process of Celgene products at the University of Chicago by working with cross-functional colleagues from home office